Abstract: This article presents the design and implementation of a generic model for fault diagnosis in electrical distribution networks, based on the Support Vector Machine (SVM) algorithm. The ...
Pattern Group Inc. (Nasdaq: PTRN), a global leader in accelerating brands on ecommerce marketplaces through proprietary technology and AI, today announced that it has acquired NextWave, a fast-growing ...
WASHINGTON — A new report from the National Academies of Sciences, Engineering, and Medicine examines how the U.S. Department of Energy could use foundation models for scientific research, and finds ...
In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...
Mistral AI, Europe's most prominent artificial intelligence startup, is releasing its most ambitious product suite to date: a family of 10 open-source models designed to run everywhere from ...
A satellite deployed to measure ocean surface heights was up to the challenge when a massive earthquake off the Kamchatka Peninsula triggered a Pacific-wide tsunami in late July. The Surface Water ...
With so much money flooding into AI startups, it’s a good time to be an AI researcher with an idea to test out. And if the idea is novel enough, it might be easier to get the resources you need as an ...
Governments and businesses globally are spending billions to develop homegrown data centers, homegrown compute clusters, and homegrown national infrastructure for AI. But having the hardware in-house ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
US Securities and Exchange Commission Chair Paul Atkins says the new listing standards will reduce barriers to access digital asset products and give investors more choice. ”This approval helps to ...
AbbVie settles with generic Rinvoq hopefuls, shielding the immunology med's US stronghold until 2037
With Rinvoq and its sibling medicine Skyrizi having successfully picked up the sales torch in the wake of Humira’s tumble over the patent cliff, AbbVie is working to cover its legal bases so the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results